RAC 0.97% $1.54 race oncology ltd

Ann: Race Develops Improved IV Formulation of Zantrene, page-12

  1. 217 Posts.
    lightbulb Created with Sketch. 75
    I’m sure I’m not the only investor appreciating the increased news flow, well done RAC team
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.